CN Patent

CN119562762A — 遗传互补组合物和方法

Assigned to University of California San Diego UCSD · Expires 2025-03-04 · 1y expired

What this patent protects

在本文的若干个示例性实施例中描述了种系互补方法和组合物，特别是NANOS3缺陷型细胞和非人动物。在一些实施例中，所述NANOS3缺陷型非人动物是种系消融的。

USPTO Abstract

在本文的若干个示例性实施例中描述了种系互补方法和组合物，特别是NANOS3缺陷型细胞和非人动物。在一些实施例中，所述NANOS3缺陷型非人动物是种系消融的。

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: CN119562762A
Jurisdiction: CN
Classification: —
Expires: 2025-03-04
Drug substance claim: No
Drug product claim: No
Assignee: University of California San Diego UCSD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.